"I am glad that taking part in a trial might help others on their own cancer journey.”
A trial of decitabine and ECF chemotherapy for advanced stomach cancer
We know that this is an especially worrying time for people with cancer and their family and friends. We have separate information about coronavirus and cancer. Please read that information alongside this page. We will update that information as guidance changes.
This trial was looking at a drug called decitabine in combination with ECF chemotherapy for advanced stomach cancer.
Doctors often treat cancer of the stomach (gastric cancer) with chemotherapy and surgery. One of the most common types of chemotherapy for stomach cancer is a combination of drugs called ECF. This is epirubicin, cisplatin and fluorouracil (5FU).
In this trial, doctors wanted to see if another drug called decitabine made ECF work better. Decitabine works by changing the activity of some of the
The aims of the trial were to find out
- The best dose of decitabine to give
- What the side effects were
- How well decitabine and ECF worked together
Summary of results
Despite attempting to contact the trial team, we have been unable to get any results for this trial.
How to join a clinical trial
Prof Mark Middleton
Experimental Cancer Medicine Centre (ECMC)
MGI Pharma Inc